Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

PARPs may be crushing it in the clinic, but half of doctors are still wary: executive
Fierce Pharma
Wed, 10/24/18 - 12:38 pm
Tags:
PARP inhibitors, physicians, Zejula, Rubraca, Lynparza, AstraZeneca, Merck, Tesaro, Clovis Oncology
AstraZeneca gets rights, options to basket of next-gen immuno-oncology therapies from Innate
BioCentury
Tue, 10/23/18 - 11:02 pm
Tags:
AstraZeneca, Innate Pharma, oncology
AstraZeneca and Ionis target diabetes with antisense approach to regenerating pancreatic cells
Fierce Biotech
Mon, 10/22/18 - 12:17 pm
Tags:
AstraZeneca, Ionis Pharmaceuticals, type 2 diabetes, antisense
Mammoth Lynparza survival win puts AZ, Merck in line for $1B launch
Fierce Pharma
Sun, 10/21/18 - 11:33 pm
Tags:
AstraZeneca, Merck, Lynparza, PARP inhibitors, BRCA-mutated ovarian cancer
ESMO18: Novartis PI3K combo therapy boosts survival in subset of breast cancer patients
Fierce Biotech
Sat, 10/20/18 - 11:10 pm
Tags:
Europe, Novartis, ESMO, AstraZeneca, breast cancer, BYL719
AstraZeneca, Merck’s Lynparza gets FDA ODD for pancreatic cancer
Pharmaceutical Business Review
Wed, 10/17/18 - 09:11 am
Tags:
AstraZeneca, Merck, Lynparza, FDA, pancreatic cancer, orphan drug
AZ to continue with investment freeze following ‘no deal’ Brexit
Pharmaforum
Tue, 10/16/18 - 11:37 am
Tags:
AstraZeneca, drug manufacturing, Brexit, UK
AstraZeneca: building a new ‘open innovation’ pharma company
PM Live
Mon, 10/15/18 - 11:57 pm
Tags:
AstraZeneca, innovation, R&D
Novo Nordisk picks AstraZeneca executive to head biopharma business
Yahoo/Reuters
Mon, 10/15/18 - 10:38 am
Tags:
Novo Nordisk, AstraZeneca, Ludovic Helfgott
3 Big Pharma Stocks Racing Along the Road to China
Motley Fool
Fri, 10/12/18 - 10:20 am
Tags:
China, cancer, Pfizer, AstraZeneca, JNJ
Entasis dips in first trading day after $75M IPO
BioCentury
Wed, 09/26/18 - 07:26 pm
Tags:
IPOs, AstraZeneca, Entasis
With CDC backing reinstated, AstraZeneca ships FluMist for the coming flu season
Fierce Pharma
Wed, 09/26/18 - 09:50 am
Tags:
AstraZeneca, FluMist Quadrivalent, vaccines, flu vaccines, CDC
Data Confirms AstraZeneca's Imfinzi Provides Unprecedented Improvement in Progression-Free Survival in Non-Small Cell Lung Cancer
CP Wire
Tue, 09/25/18 - 11:50 am
Tags:
AstraZeneca, MedImmune, Imfinzi, non-small cell lung cancer
Tue, 09/25/18 - 09:51 am
Tags:
AstraZeneca, Imfinzi, non-small cell lung cancer
AstraZeneca CEO Pascal Soriot: ‘I’m the lowest-paid CEO in the whole industry’
Endpoints
Mon, 09/24/18 - 11:12 pm
Tags:
AstraZeneca, Pascal Soriot, Pharma CEOs, executive pay
Farxiga Meets One Primary Endpoint in Large Ph III Cardiovascular Outcomes Trial in 17,000 Patients with Type 2 Diabetes
CP Wire
Mon, 09/24/18 - 10:01 am
Tags:
AstraZeneca, Farxiga, Dapagliflozin, clinical trials, type 2 diabetes, cardiovascular disease
PhaseBio details dollars in AstraZeneca deal as it rolls out a plan for $86M-plus IPO
Endpoints
Mon, 09/24/18 - 09:44 am
Tags:
PhaseBio, IPOs, PB2452, anti-anti-coagulants, AstraZeneca
Mon, 09/24/18 - 09:36 am
Tags:
AstraZeneca, Farxiga
AstraZeneca CEO warns of medicine shortages after Brexit: Sunday Times
Yahoo/Reuters
Sun, 09/23/18 - 01:47 pm
Tags:
UK, Brexit, AstraZeneca, Pascal Soriot, drug shortages
AZ expands role in China, to include robots and health tech
Pharmaforum
Thu, 09/20/18 - 10:03 am
Tags:
AstraZeneca, China, robotics, digital health, artificial intelligence

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.